Clinical Trial Update: Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update shows completion of a study evaluating Tarceva (erlotinib) in combination with Capecitabine and Oxaliplatin for metastatic colorectal cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Tarceva (erlotinib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Colorectal Cancer, Neoplasm Metastasis | Phase 2 | Status: COMPLETED